RenovoRx RNXT
NASDAQ RNXT
$1.59 +0.04 (+2.26%)
As of: Oct 2, 2026 · 1:54 PM EDT

RenovoRx (RNXT) Price to Sales (2025 - 2026)

Updated

RenovoRx's (RNXT) Price to Sales stood at 22.38 in Q2 2026, down 26.8% from the prior quarter.

Analysis

RenovoRx (RNXT) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, RenovoRx's Price to Sales came in at 27.39, down 96.2% from FY2024.

  • Across earlier years, Price to Sales came in at 721.04 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 RenovoRx 70.39 Mn 70.39 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.38
Mar 31, 2026 30.56
Dec 31, 2025 27.39
API Access

RenovoRx Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=RNXT&period=max&api_key=YOUR_API_KEY